Thailand · Delayed Price · Currency is THB Bio Green Energy Tech PCL Statistics
Total Valuation
BKK:BIOTEC has a market cap or net worth of THB 824.41 million. The enterprise value is 1.23 billion.
| Market Cap | 824.41M |
| Enterprise Value | 1.23B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BKK:BIOTEC has 3.05 billion shares outstanding.
| Current Share Class | 3.05B |
| Shares Outstanding | 3.05B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 45.68% |
| Owned by Institutions (%) | 0.02% |
| Float | 1.06B |
Valuation Ratios
The trailing PE ratio is 4.49.
| PE Ratio | 4.49 |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| PB Ratio | 0.68 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | 28.00 |
| P/OCF Ratio | 12.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.33, with an EV/FCF ratio of 41.91.
| EV / Earnings | 6.73 |
| EV / Sales | 0.28 |
| EV / EBITDA | 5.33 |
| EV / EBIT | 8.07 |
| EV / FCF | 41.91 |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.37.
| Current Ratio | 0.71 |
| Quick Ratio | 0.42 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 1.95 |
| Debt / FCF | 15.28 |
| Interest Coverage | 6.18 |
Financial Efficiency
Return on equity (ROE) is 16.45% and return on invested capital (ROIC) is 7.87%.
| Return on Equity (ROE) | 16.45% |
| Return on Assets (ROA) | 3.98% |
| Return on Invested Capital (ROIC) | 7.87% |
| Return on Capital Employed (ROCE) | 10.33% |
| Weighted Average Cost of Capital (WACC) | 2.53% |
| Revenue Per Employee | 22.24M |
| Profits Per Employee | 912,760 |
| Employee Count | 201 |
| Asset Turnover | 1.86 |
| Inventory Turnover | 17.58 |
Taxes
In the past 12 months, BKK:BIOTEC has paid 37.49 million in taxes.
| Income Tax | 37.49M |
| Effective Tax Rate | 16.91% |
Stock Price Statistics
The stock price has increased by +35.00% in the last 52 weeks. The beta is -0.51, so BKK:BIOTEC's price volatility has been lower than the market average.
| Beta (5Y) | -0.51 |
| 52-Week Price Change | +35.00% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 52.74 |
| Average Volume (20 Days) | 7,591,424 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:BIOTEC had revenue of THB 4.47 billion and earned 183.46 million in profits. Earnings per share was 0.06.
| Revenue | 4.47B |
| Gross Profit | 284.53M |
| Operating Income | 152.81M |
| Pretax Income | 221.72M |
| Net Income | 183.46M |
| EBITDA | 221.85M |
| EBIT | 152.81M |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 46.70 million in cash and 449.87 million in debt, with a net cash position of -403.17 million or -0.13 per share.
| Cash & Cash Equivalents | 46.70M |
| Total Debt | 449.87M |
| Net Cash | -403.17M |
| Net Cash Per Share | -0.13 |
| Equity (Book Value) | 1.22B |
| Book Value Per Share | 0.40 |
| Working Capital | -305.24M |
Cash Flow
In the last 12 months, operating cash flow was 66.43 million and capital expenditures -36.99 million, giving a free cash flow of 29.44 million.
| Operating Cash Flow | 66.43M |
| Capital Expenditures | -36.99M |
| Depreciation & Amortization | 69.04M |
| Net Borrowing | -188.50M |
| Free Cash Flow | 29.44M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 6.37%, with operating and profit margins of 3.42% and 4.12%.
| Gross Margin | 6.37% |
| Operating Margin | 3.42% |
| Pretax Margin | 4.96% |
| Profit Margin | 4.12% |
| EBITDA Margin | 4.96% |
| EBIT Margin | 3.42% |
| FCF Margin | 0.66% |
Dividends & Yields
BKK:BIOTEC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 22.25% |
| FCF Yield | 3.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BKK:BIOTEC has an Altman Z-Score of 1.88 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.88 |
| Piotroski F-Score | 7 |